tradingkey.logo

tradingkey.logo
怜玢


Tivic Health Systems Ord Shs

VBIO
りォッチリストに远加
0.487USD
-0.015-2.99%
取匕時間 11/06, 12:23ET
1.05M時䟡総額
損倱額盎近12ヶ月PER

Tivic Health Systems Ord Shsに぀いお 䌁業名

Valion Bio, Inc., formerly Tivic Health Systems, Inc., is a late-stage immunotherapeutics company. The Company offers Entolimod, which is a drug used to treat acute radiation syndrome (ARS). Entolimod is a toll-like receptor 5 (TLR5) agonist that activates an innate immune pathway to prevent cell death in the bone marrow and epithelial tissues across systems impacted by radiation and age. Its pipeline also includes Entolimod to treat neutropenia and lymphocyte exhaustion, as well as Entolasta, an immunologically optimized variant of Entolimod for chronic applications. Its subsidiary, Velocity Bioworks, is a full-service contract development and manufacturing organization (CDMO) that is based in San Antonio, Texas. It offers upstream and downstream process development and optimization; analytical testing, assay development, and qualification; quality control and stability testing; microbial and mammalian expression systems; technology transfer and program management services.

Tivic Health Systems Ord Shs プロフィヌル


䌁業コヌド- -
䌚瀟名- -
䞊堎日- -
最高経営責任者「CEO」- -
埓業員数- -
蚌刞皮類- -
決算期末- -
本瀟所圚地- -
郜垂- -
蚌刞取匕所- -
囜- -
郵䟿番号- -
電話番号- -
りェブサむト- -
䌁業コヌド- -
䞊堎日- -
最高経営責任者「CEO」- -

Tivic Health Systems Ord Shsの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Ms. Sheryle J. Bolton
Ms. Sheryle J. Bolton
Independent Chairman of the Board
Independent Chairman of the Board
400.00
--
Mr. Dean Zikria
Mr. Dean Zikria
Interim Chief Executive Officer, Director
Interim Chief Executive Officer, Director
--
--
Mr. Jim Hock
Mr. Jim Hock
Investor Relations
Investor Relations
--
--
Ms. Lisa Wolf
Ms. Lisa Wolf
President, Chief Financial Officer, Chief Operating Officer
President, Chief Financial Officer, Chief Operating Officer
--
--
Ms. Christina Valauri
Ms. Christina Valauri
Independent Director
Independent Director
--
--
Mr. Michael K. Handley
Mr. Michael K. Handley
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jared Malbin
Mr. Jared Malbin
Director
Director
--
--
Mr. Thomas H. Jensen
Mr. Thomas H. Jensen
Chairman of the Board
Chairman of the Board
--
--
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Ms. Sheryle J. Bolton
Ms. Sheryle J. Bolton
Independent Chairman of the Board
Independent Chairman of the Board
400.00
--
Mr. Dean Zikria
Mr. Dean Zikria
Interim Chief Executive Officer, Director
Interim Chief Executive Officer, Director
--
--
Mr. Jim Hock
Mr. Jim Hock
Investor Relations
Investor Relations
--
--
Ms. Lisa Wolf
Ms. Lisa Wolf
President, Chief Financial Officer, Chief Operating Officer
President, Chief Financial Officer, Chief Operating Officer
--
--
Ms. Christina Valauri
Ms. Christina Valauri
Independent Director
Independent Director
--
--
Mr. Michael K. Handley
Mr. Michael K. Handley
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--

よくある質問

Tivic Health Systems Ord Shsの䞊䜍5名の株䞻は誰ですか


Tivic Health Systems Ord Shsの䞊䜍5名の株䞻は以䞋のずおりです。Ms. Sheryle J. Bolton
tradingkey.logo
リスク告知圓瀟りェブサむト及びモバむルアプリは特定の投資商品に関する䞀般的な情報のみを提䟛しおおり、Finsightsは金融アドバむスや投資商品の掚奚を行うものではありたせん。本情報の提䟛をもっおFinsightsが投資助蚀を行っおいるず解釈されるこずはありたせん。
投資商品には元本割れを含む重倧なリスクが䌎い、党おの投資家に適するものではありたせん。なお、過去の運甚実瞟は将来の成果を保蚌するものではありたせん。
Finsightsは、第䞉者広告䞻たたは提携先が圓瀟りェブサむト・モバむルアプリ䞊に広告を掲茉するこずを蚱可する堎合があり、これら広告䞻から広告ぞの反応に基づく報酬を受けるこずがありたす。
© 著䜜暩: FINSIGHTS MEDIA PTE. LTD. 無断耇写・転茉を犁じたす。